Ariel Zhang, PhD was awarded a 2026 Next Generation Research Grant in Peripheral Neuropathy. Dr. Zhang will explore the role of a protein called ATF2 in chemotherapy-induced peripheral neuropathy (CIPN) and investigate if reducing the protein can protect against this condition. If so, this could pave the way for the development of safer cancer treatments. This research is funded by The Foundation for Peripheral Neuropathy.

Ariel Zhang, PhD was awarded a Next Generation Research Grant in #PeripheralNeuropathy.

Institution: @temple.edu
This research is funded by @foundationforpn.bsky.social.

More ➡️ buff.ly/PFtLmrI
#PeripheralNeuropathyResearch

Christopher Cashman, MD, PhD was awarded a 2026 Next Generation Research Grant in Peripheral Neuropathy. Dr. Cashman will study a specific type of genetically inherited peripheral neuropathy and determine what role damaged mitochondria might play in the disease. If a direct connection is proven, targeting damaged mitochondria could help treat the condition. This research is funded by The Foundation for Peripheral Neuropathy.

Christopher Cashman, MD, PhD was awarded a Next Generation Research Grant in #PeripheralNeuropathy.

Institution: @mgbresearch.bsky.social & @harvardmed.bsky.social
This research is funded by @foundationforpn.bsky.social.

More ➡️ buff.ly/UoMmVso
#PeripheralNeuropathyResearch

Advocacy work pays off:
Nearly $20 million in DoD funds for PN research in recent years.

We make sure PN is an eligible research topic by getting it renewed every year

Today is FPN Day | Celebrating 18 years of FPN
#peripheralneuropathy #peripheralneuropathyresearch #FPNday

Discover the urgent need for increased research funding for peripheral neuropathy: www.foundationforpn.org/advocating-f...
#PNadvocacy #neuropathy #peripheralneuropathy #peripheralneuropathyresearch #PNresearch